Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals

27 octobre 2021 mis à jour par: University Hospital, Basel, Switzerland

Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals - an International Online Survey of Psychosomatic, Psychiatric and Psychological Consultation and Liaison (C&L) Services

Heads of all psychosomatic, psychiatric and psychological consultation and liaison (C&L) services in acute care hospitals across all participating countries will be contacted and asked to participate in this international cross-sectional online survey. The survey consists of questions about care structures and their utilisation that psychosomatic, psychiatric and psychological C&L services have established in acute hospitals in the context of the COVID 19 pandemic.

Aperçu de l'étude

Statut

Complété

Intervention / Traitement

Description détaillée

Background:

The COVID-19 pandemic raised new challenges in supporting patients, relatives and staff for psychosomatic, psychiatric and psychological C&L services in general hospitals worldwide. It is intended to build upon the experience gained so far in order to be well prepared for the future.

Objectives:

The aims of this international online survey are

  1. To summarize the efforts made in psychosocial care in the context of the COVID-19 pandemic.
  2. To assess the experiences made with the established services so far.
  3. To assess the need for networking, cooperation and support.
  4. Improvement of psychosocial care in acute hospitals in the context of pandemics.

Study Design:

This health services research project will be carried out as an observational study in the form of an international cross-sectional online survey.

There will be one survey time point. Study reporting will follow the STROBE Statement (Strengthening the Reporting of Observational Studies in Epidemiology).

Ethic approval:

In all participating countries the respective ethics committees were informed about the survey and it was checked with them, how far and what kind of country-specific vote of an ethics committee was necessary. Written statements, declarations or votes were obtained from all participating countries.

Setting:

The heads of all psychosomatic, psychiatric and psychological C&L services in acute care hospitals across all participating countries are contacted and asked to participate. Contact is made via the respective national professional societies and relevant working and interest groups.

Participants This study is an international online survey with psychosomatic, psychiatric and psychological C&L services from 14 European countries (Austria, Belgium, Finland, Germany, France, Greece, Ireland, Italy, Norway, Poland, Portugal, Spain, Switzerland, United Kingdom) as well as parts of Canada (Quebec and Ontario region) and Iran participating.

Country specific regions:

The national coordinators of the participating country provided lists of specific regions for their respective country following the NUTS logic (Nomenclature of Territorial Units for Statistics; https://en.wikipedia.org/wiki/Nomenclature_of_Territorial_Units_for_Statistics), preferably a NUTS level that leads to 5 - 20 NUTS for each country.

Online survey questionnaire:

Self-developed questionnaire based on relevant literature, own experience and consultation with participating professional societies. The survey contains 25 questions on structural and process variables regarding characterization of the participating C&L services, involvement of the respective hospitals in the physical care of COVID-19 patients, structures / organization of psychosocial care for COVID-19 patients in the participating hospitals, specific psychosocial support for patients, relatives and staff established in the participating hospital in the context of COVID-19, communication - How the different target groups were informed about the COVID-19 related psychosocial support services and offers, burden of the COVID-19 pandemic on the psychosocial C&L teams, needs and wishes for the future.

The study questionnaire was translated by a professional company from German into English, French and Italian. Language harmonization and cultural adaptation followed a modified committee-based approach informed by the European Social Survey (ESS) Round 9 Translation Guidelines. Participants are free to choose the language version to be worked on.

Type d'étude

Observationnel

Inscription (Réel)

230

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Bayern
      • Nürnberg, Bayern, Allemagne, 90419
        • Nuremberg Hospital, Department of Psychosomatic Medicine and Psychotherapy
    • Nordrhein-Westfalen
      • Köln, Nordrhein-Westfalen, Allemagne, 50937
        • University Hospital Cologne, Department of Psychosomatics and Psychotherapy
      • Ghent, Belgique
        • Ghent University Hospital, Department of Psychiatry
      • Montreal, Canada
        • University of Montreal, Department of Psychosomatic Medicine
      • Toronto, Canada
        • TorontoSinai Health, University of Toronto, Department of Psychiatry
      • Barcelona, Espagne
        • Barcelona University
      • Oulu, Finlande, 90220
        • Oulu University Hospital and University of Oulu
      • Paris, France
        • Université de Paris, Service de Psychiatrie de l'adulte
      • Thessaloniki, Grèce
        • Aristotle University Thessaloniki
      • Tehran, Iran (République islamique d
        • University of Medical Sciences, Department of Psychiatry
      • Dublin, Irlande
        • University College Dublin
      • Bologna, Italie, 40123
        • Bologna University
      • Modena, Italie, 411274
        • University of Modena & Reggio Emilia
    • Steiermark
      • Graz, Steiermark, L'Autriche, 8036
        • Medical University of Graz, University Hospital Graz
      • Lisboa, Le Portugal
        • Hospital de Santa Maria
      • Lisboa, Le Portugal
        • Universidade Católica Portuguesa Lisboa
      • Oslo, Norvège
        • Oslo University Hospital
      • Wroclaw, Pologne
        • Wroclaw Medical University
      • Exeter, Royaume-Uni
        • University of Exeter
      • York, Royaume-Uni
        • University of York
      • Basel, Suisse, 4002
        • University of Basel, Department of Psychiatry (UPK)
    • Basel-City
      • Basel, Basel-City, Suisse, 4031
        • University Hospital Basel, Department of Psychosomatic Medicine

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

The heads of all psychosomatic, psychiatric and psychological C&L services in acute care hospitals across all participating countries will be contacted and asked to participate. Contact will be made via the respective national professional societies and relevant working and interest groups

La description

Inclusion Criteria:

  • heads of all psychosomatic, psychiatric and psychological C&L services in acute care hospitals across all participating countries

Exclusion Criteria:

  • None

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Structural and process quality of COVID-19 related psychosocial C&L services
Délai: 6 months

Data basis for improving quality of COVID-19 related psychosocial C&L services:

  1. characterization of participating C&L services
  2. involvement of respective hospitals in the physical care of COVID-19 patients
  3. structures/ organization of psychosocial care for COVID-19 patients in participating hospitals
  4. specific psychosocial support established in participating hospitals in context of COVID-19 for

    1. patients
    2. relatives
    3. staff
  5. communication strategies - How the different target groups were informed about COVID-19 related psychosocial support services and offers
  6. burden of COVID-19 pandemic on psychosocial C&L teams
  7. needs and wishes of the participating psychosocial C&L services

    1. for support or exchange of experience regarding psychosocial care in the COVID 19 context
    2. for changes / improvements considered essential for the future with regard to psychosocial care services in the participating hospitals in the COVID-19 context
6 months

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Rainer Schaefert, Prof. Dr. med., University Hospital, Basel, Switzerland

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

8 décembre 2020

Achèvement primaire (Réel)

3 octobre 2021

Achèvement de l'étude (Réel)

3 octobre 2021

Dates d'inscription aux études

Première soumission

11 février 2021

Première soumission répondant aux critères de contrôle qualité

11 février 2021

Première publication (Réel)

15 février 2021

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

28 octobre 2021

Dernière mise à jour soumise répondant aux critères de contrôle qualité

27 octobre 2021

Dernière vérification

1 octobre 2021

Plus d'information

Termes liés à cette étude

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner